Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin
about
Calsarcins, a novel family of sarcomeric calcineurin-binding proteinsMyozenin: an alpha-actinin- and gamma-filamin-binding protein of skeletal muscle Z linesCharacterization of human palladin, a microfilament-associated proteinCalsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteinsIdentification of filamin C as a new physiological substrate of PKBalpha using KESTRELmyotilin Mutation found in second pedigree with LGMD1ADifferent splice variants of filamin-B affect myogenesis, subcellular distribution, and determine binding to integrin [beta] subunitsFilamin A, the Arp2/3 complex, and the morphology and function of cortical actin filaments in human melanoma cellsStructural Determinants of Integrin Binding to the Talin RodIdentification of Xin-repeat proteins as novel ligands of the SH3 domains of nebulin and nebulette and analysis of their interaction during myofibril formation and remodelingIncreased filamin binding to beta-integrin cytoplasmic domains inhibits cell migrationMyotilin dynamics in cardiac and skeletal muscle cellsFilamin C interacts with the muscular dystrophy KY protein and is abnormally distributed in mouse KY deficient muscle fibresA class III PDZ binding motif in the myotilin and FATZ families binds enigma family proteins: a common link for Z-disc myopathiesMyofibrillar myopathiesAnalysis of myotilin turnover provides mechanistic insight into the role of myotilinopathy-causing mutationsXin, an actin binding protein, is expressed within muscle satellite cells and newly regenerated skeletal muscle fibersLoss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structureTargeted Deletion of the Muscular Dystrophy Gene myotilin Does Not Perturb Muscle Structure or Function in MiceA New Insight into the Role of Calpains in Post-mortem Meat Tenderization in Domestic Animals: A review.Filamins in mechanosensing and signaling.A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy.A combined laser microdissection and mass spectrometry approach reveals new disease relevant proteins accumulating in aggregates of filaminopathy patientsNovel recessive myotilin mutation causes severe myofibrillar myopathy.Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction.New insights into the protein aggregation pathology in myotilinopathy by combined proteomic and immunolocalization analyses.Diagnostic immunohistochemistry in neuromuscular disorders.Pathophysiology of protein aggregation and extended phenotyping in filaminopathy.Ribosomal S6 kinase (RSK) regulates phosphorylation of filamin A on an important regulatory siteControl of high affinity interactions in the talin C terminus: how talin domains coordinate protein dynamics in cell adhesions.Molecular pathology of myofibrillar myopathies.The role of the C-terminus for functional heteromerization of the plant channel KDC1.Cardiac-specific ablation of Cypher leads to a severe form of dilated cardiomyopathy with premature death.Filamin C-related myopathies: pathology and mechanisms.Clinical and myopathological evaluation of early- and late-onset subtypes of myofibrillar myopathy.Role of the sarcomeric Z-disc in the pathogenesis of cardiomyopathy.Myofibrillar Z-discs Are a Protein Phosphorylation Hot Spot with Protein Kinase C (PKCα) Modulating Protein Dynamics.Homozygosity of the Dominant Myotilin c.179C>T (p.Ser60Phe) Mutation Causes a More Severe and Proximal Muscular Dystrophy.Overview of the Muscle Cytoskeleton.Filamin C is a highly dynamic protein associated with fast repair of myofibrillar microdamage.
P2860
Q24290615-57535AED-CA96-4C21-98BE-84027BE72E05Q24290814-153BC2BA-A433-48C6-8A6E-C292CB6B8D4EQ24291793-94B634DB-7F3E-462A-AD98-AEE5AD690435Q24292289-0F645826-C596-46DE-BF8C-390F47F5B49FQ24528134-2D13E2A6-5163-4BB1-BE84-143D70D134B9Q24616089-48368A10-0C4F-421E-998F-013DAC7A9421Q24652710-E7DB3551-E87A-4ACC-8C95-07FFCE5BBA8AQ24653378-5A6DE51D-098C-4C0C-A725-7C66C3299E53Q27653581-73D218B8-B42C-41BA-A914-90B5463BBC76Q27679820-8284145B-8661-4A61-B5E0-A225CF3748F5Q28214955-12CFCE27-E36C-4055-BB79-2057A3DD4C48Q28251196-D3DA433C-1F9A-400A-8B5F-EE21CFA02B02Q28283658-29839F5A-EDFF-46DC-8254-0D8FD4C12F4BQ28302336-F5A1A659-B0B9-4E53-91A1-D8C2478BAF7DQ28303812-B1121A67-D3E0-4331-A89C-5E20814BCD7FQ28306262-706C891B-44FF-4E0C-9823-BF514C6C800DQ28589167-23A09F94-EF37-4DF7-B951-84B50686A853Q28594543-DACC5648-1CFC-4EF3-A6AD-CAA08C7E6494Q29037453-16B01F89-7662-4DFC-97A8-9175D87F3C09Q33886192-81BCC2D5-2D2A-4F12-91FE-A0453070D4ABQ33900830-315A87DD-819F-4EA1-AF5A-D88638E40DC4Q34015436-2DCE0B5A-7882-4DC7-BA56-3C6B8BD7464DQ34463331-8A5B5DFC-4737-4562-B44B-DA4D3CEB7054Q35187989-999B9C09-9F16-4CC1-BD3B-1DD66A761290Q35721399-24D592B5-AA81-4D5B-8D46-A9FD0F3B307DQ35913983-B7FCDC41-07A3-4C3A-B9B8-2EB9AC04513BQ36012956-2B31A0AB-153E-4B26-8E49-7E75D36AA42AQ36218715-EC01AAA2-B7A6-463D-A169-04CAF9FB2E8DQ37012461-0BA331E7-C816-49F4-A968-568459A5C4C7Q37185310-C41C7081-30B1-4F94-87B7-FFD636DA4D44Q37258743-1EB64BAA-24EB-4E91-A093-60E627535D1EQ37265709-A792E8A4-7593-435E-BD68-C8039C668463Q37292925-95DF5FC6-A01C-4200-BCB5-503FC0E1B4B8Q37450673-96A27442-9EFC-4BC5-A5FC-5E08D9B95DB5Q37490172-06F273F6-D796-44B2-A18E-B4E6220C5484Q37608582-EFDA6A5F-CCEC-4C1B-80C6-1F65C359C4C3Q38724052-19CE6461-EAF5-4E20-A8B1-F65DF1F504B0Q39181390-AA4E4850-996F-4325-B407-243823BDA6C3Q39391006-69342594-74F5-427E-89B6-D9841F813C89Q39748665-D017DAC4-8318-4A82-8CA8-51B857E23091
P2860
Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Indications for a novel muscul ...... oform, interacts with myotilin
@ast
Indications for a novel muscul ...... oform, interacts with myotilin
@en
Indications for a novel muscul ...... oform, interacts with myotilin
@en-gb
Indications for a novel muscul ...... oform, interacts with myotilin
@nl
type
label
Indications for a novel muscul ...... oform, interacts with myotilin
@ast
Indications for a novel muscul ...... oform, interacts with myotilin
@en
Indications for a novel muscul ...... oform, interacts with myotilin
@en-gb
Indications for a novel muscul ...... oform, interacts with myotilin
@nl
prefLabel
Indications for a novel muscul ...... oform, interacts with myotilin
@ast
Indications for a novel muscul ...... oform, interacts with myotilin
@en
Indications for a novel muscul ...... oform, interacts with myotilin
@en-gb
Indications for a novel muscul ...... oform, interacts with myotilin
@nl
P2093
P2860
P356
P1476
Indications for a novel muscul ...... oform, interacts with myotilin
@en
P2093
A Taivainen
D Auerbach
D Pacholsky
P F van der Ven
P Salmikangas
R Schröder
P2860
P304
P356
10.1083/JCB.151.2.235
P407
P577
2000-10-16T00:00:00Z